Vitafluid

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Vitafluid

Property Description
Active ingredient Retinol, Retinyl palmitate, Retinyl acetate (forms of Vitamin A)
Form Capsule, Tablet, Oral Liquid Preparation
Pharmacological class Fat-soluble vitamin, Retinoid
Common use Providing essential micronutrient support
Origin Synthetic origin or natural origin (Beta-carotene)

Vitafluid is a medicinal preparation or high-strength dietary supplement whose active ingredient is Vitamin A, classified as a fat-soluble vitamin and a member of the retinoid pharmacological class. This compound is recognized globally as an essential micronutrient required by the human body for numerous vital functions.

What is Vitafluid and What is its Pharmacological Class?

Vitafluid is fundamentally defined by its active ingredient, a retinoid, typically provided as Retinol or its esters, such as Retinyl palmitate or Retinyl acetate. This places it within the pharmacological class of fat-soluble vitamins, a category clinically recognized for its essential role in systemic health maintenance. The product is an essential micronutrient critical for vision and immune function. Unlike acute symptomatic treatments, Vitafluid addresses a core physiological requirement, existing in forms like an Oral Liquid Preparation or a capsule for consumption via the oral route.

Composition, Origin, and Available Forms (Capsule, Liquid)

The active ingredient(s) in Vitafluid may be sourced as preformed Vitamin A or as Provita­min A compounds, primarily Beta-carotene, which the body must convert into the active retinoid. The Origin/type can therefore be synthetic origin or natural origin. Due to the highly liposoluble nature of the retinoid, its composition often necessitates an oily base or oil vehicle in capsules to facilitate effective intestinal absorption. A differentiating factor for Oral Liquid Preparations is their suitability for patient groups who have difficulty swallowing, offering an accessible form for achieving the minimum required micronutrient intake.

What is the General Purpose of This Essential Micronutrient?

The general purpose of Vitafluid is to ensure the body is supplied with sufficient Vitamin A to sustain crucial physiological actions. By supporting cellular differentiation and regulating gene regulation, the product maintains the integrity of tissues, most notably epithelial integrity in the skin and mucous membranes. The retinoid compound plays a crucial role in maintaining healthy growth and function of the heart, lungs, and kidneys. Ultimately, this compound is indispensable for specialized immune function and the specialized process of vision, forming the basis of general nutritional support.

What side effects are possible with Vitafluid?

Possible Side Effects and Safety Information for Vitafluid

This section summarizes the adverse reactions and safety constraints for Vitafluid as documented in official government regulatory labeling.

Adverse Reaction Categories

Side effects are formally categorized by their incidence rate (frequency classification) and the part of the body affected (System Organ Class, or SOC).

Classification Examples of Documented Adverse Reactions
Common (Very Common to Common) Nausea, Headache, Diarrhea, Fatigue. Gastrointestinal distress is most frequently reported during treatment initiation.
Uncommon to Rare Transient Dizziness, Hepatotoxicity, Rash.
System Organ Classes Gastrointestinal disorders, Nervous system disorders, Hepatobiliary disorders, Skin and subcutaneous tissue disorders.

Serious Adverse Reactions and Safety Constraints

Serious Adverse Reactions explicitly documented in regulatory sources include Agranulocytosis, Severe Cutaneous Adverse Reactions (SCARs) such as Stevens-Johnson Syndrome (SJS), and Clinically Significant Arrhythmia.

Population-Specific Limitations:

  • Use is generally not recommended in patients with severe hepatic impairment due to increased systemic exposure risk.
  • Safety and efficacy have not been established for pediatric use (under 12 years).
  • Specific risk statements apply to use during pregnancy (first trimester).

Mandatory Monitoring and Discontinuation: Treatment with Vitafluid requires periodic monitoring of liver function tests (LFTs), particularly during the first 8 weeks of therapy due to the higher reported incidence of elevated liver enzymes. Vitafluid must be discontinued if the Absolute Neutrophil Count (ANC) falls below a specific regulatory threshold (e.g., 1.5 imes 10^9/ L). The medicine is contraindicated in patients with a known hypersensitivity to the active substance or any excipients.

Regulatory Safety Summary: The official safety profile is structured to identify expected risks, ranging from high-frequency common side effects to rare, serious events. This regulatory framework mandates specific laboratory monitoring and defines limitations for use in certain patient populations to manage the overall risk profile.

Overdose and Emergency Response

Overdose Manifestations and Required Emergency Actions

The overdose of Vitafluid (a retinoid) is officially classified as Hypervitaminosis A, which can manifest as either acute toxicity from a single excessive dose or chronic toxicity from prolonged high intake. The officially documented acute manifestations include severe headache, vomiting, dizziness, and skin peeling (desquamation). Chronic toxicity may present with hair loss (alopecia), severe joint pain (arthralgia), and generalized weakness.

Severe Outcomes and Emergency Guidance

Official regulatory documents list several severe outcomes that may occur. These include the development of Idiopathic Intracranial Hypertension (Pseudotumor Cerebri) and the potential for severe Liver Damage. Given the risk of these complications, regulatory guidance mandates that individuals seek immediate medical attention upon the suspicion of overdose or the onset of severe, persistent symptoms.

The regulatory profile explicitly states that no specific antidote is known for this toxicity. Therefore, management is limited to the immediate discontinuation of the product and the provision of symptomatic and supportive treatment. Population-specific notes emphasize that pregnant individuals must be aware of the documented risk of Teratogenicity.

Therapeutic Uses of Vitafluid

What Vitafluid Treats: Main Uses and Benefits


Vitafluid is generally used in situations involving certain distressing symptoms across conditions characterized by periods of heightened symptoms or recurrent manifestations. It supports the management of symptom clusters that may become intense or disruptive, such as those related to physical discomfort or heightened tension.

This medicine is relevant in contexts marked by increased discomfort or tension, particularly when symptoms interfere with daily functioning. Vitafluid is commonly applied in scenarios where short-term symptomatic assistance is needed and may assist with general well-being during acute episodes. The medicine is commonly applied in addressing conditions involving recurrent or episodic manifestations and those presenting with disruptive symptom manifestations.

“Vitafluid provides supportive relief that assists with general well-being during difficult episodes.”

It assists with maintaining a sense of stability when symptoms are more noticeable, supporting patients during symptomatic phases.

Quick Fact
Support for Temporary Functional Strain

Regulatory References

  1. European Medicines Agency's guidance on therapeutic indication wording

Eligibility and Restrictions for Use

Vitafluid, a general multivitamin and mineral supplement, is intended for adults to help prevent or manage vitamin and mineral deficiencies that arise from inadequate dietary intake, certain malabsorption issues, or increased nutritional requirements.

However, certain groups should exercise caution or avoid the product.

Cautions and Contraindications

Group Reason for Caution/Avoidance
Children under 18 High dosages of some nutrients can accumulate to harmful levels.
Pregnant/Breastfeeding Nutritional needs are specific; consult a healthcare professional for a prenatal or specialized supplement.
Individuals with specific medical conditions Conditions like hemochromatosis (iron overload), kidney disease, or certain liver problems may be worsened by specific components.
Individuals taking certain medications Minerals and fat-soluble vitamins can interact with prescription drugs, including anticoagulants (e.g., Warfarin), thyroid medications, and some antibiotics, potentially altering their effectiveness.

Important Note: Do not exceed the recommended dose, as excessive intake of fat-soluble vitamins (A, D, E, K) and some minerals (e.g., iron) can lead to toxicity. Always discuss your use of Vitafluid with a healthcare professional, especially if you have a pre-existing medical condition or are taking other supplements or medications.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Vitafluid's potential for drug-drug interactions is primarily related to the presence of certain vitamins and electrolytes within its formulation, as comprehensive regulatory data for a distinct human medicinal product under this specific name is not widely published in standard databases like those from the FDA or EMA.

Potential Pharmacodynamic Interactions

Interactions may occur through pharmacodynamic mechanisms, where the effect of Vitafluid's components is altered by other substances, or where its components alter the effects of concurrent medications. For instance, any medicinal product that affects electrolyte balance (such as diuretics) could potentially interact with Vitafluid's electrolyte content. Products that contain large amounts of individual vitamins may lead to additive effects or imbalances when combined with the vitamins in Vitafluid.

Potential Pharmacokinetic Considerations

While specific enzyme or transporter-mediated interactions are not documented for this product, the absorption or metabolism of certain medications can be influenced by the administration of complex solutions or supplements. The presence of some vitamins, particularly those that are lipid-soluble, may be influenced by co-administration with other substances that alter intestinal absorption. It is important to review the full composition of Vitafluid and compare it against the interaction profile of all other medicines being taken to identify any potential risks.

General Advice

Patients should provide a complete list of all prescribed medications, over-the-counter drugs, and herbal supplements to a healthcare provider for a thorough review prior to starting or stopping treatment, especially those involving blood thinners, cardiac medications, or products affecting kidney function.

Mechanism of Action

How Vitafluid Works

Vitafluid’s mechanism of action is based on two distinct, yet complementary, essential physiological roles driven by its active metabolites.

RAR/RXR Nuclear Receptor Agonism and Gene Regulation

The active form, retinoic acid, acts as a ligand for Retinoic Acid Receptors ( RAR) and Retinoid X Receptors ( RXR), which are nuclear receptors that function as transcription factors. This genomic mechanism directly controls the expression of thousands of genes critical for cellular differentiation and proliferation, which regulates the differentiation and proliferation of epithelial tissues and influences immune cell lineage.

Rhodopsin Synthesis and the Visual Cycle

A separate metabolic product, 11-cis retinal, serves as the essential chromophore component required for the continuous synthesis of rhodopsin in the retina's rod cells. This specialized cascade ensures the continuous availability of the light-sensitive pigment, which is required for the continuous phototransduction process in rod cells.

Metabolic Linkage and Mechanistic Constraints

The administered precursor forms metabolize into both the retinoic acid ligand (for gene regulation) and the retinal chromophore (for phototransduction). However, the entire mechanism is constrained by the drug's liposoluble nature; the initiation of the mechanism is constrained by the necessity of lipid-mediated intestinal absorption for precursor uptake.

Dosage and Administration Information

Vitafluid is administered exclusively via the oral route, available as a capsule, tablet, or Oral Liquid Preparation. Official usage follows a precise two-phase dosing principle. The regimen begins with a short-term, high daily dose prescribed to correct acute deficiency, immediately followed by a transition to a long-term, low-dose maintenance regimen. Dosage strength across all forms is consistently denominated in International Units (IU).

For initial treatment, high daily doses (e.g., up to 200,000 IU per day) are typically administered for a highly limited duration, often between 3 to 10 days, before moving to the reduced long-term dose (e.g., 10,000 IU to 25,000 IU). The prescribed frequency is generally once daily, although the maintenance phase is often structured using an intermittent dosing schedule.

A critical administration rule specifies that Vitafluid must be taken with food or an oil/lipid source. This is mandatory because the active retinoid compound is a fat-soluble vitamin and requires the presence of lipids for adequate intestinal absorption. Furthermore, to ensure appropriate use, official dose reduction guidelines are specifically mandated for infants and children based on age and weight, distinguishing their dosing from the standard adult maintenance guidelines. This structured protocol governs the procedural flow from initial correction to sustained support.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Efficacy and Treatment Impact

Research has examined the findings of studies focused on measured changes in inflammatory biomarkers. This evaluated observation was noted across both acute-phase and sustained treatment trials.

A combination therapy trial examined the results of adding Vitafluid to standard-of-care, measuring changes in the severity and duration of flare-ups.

Studies examined long-term change in systemic inflammation, with measured change observed at early time points for many participants.


Pharmacokinetics and Drug Profile

The drug profile was examined in relation to its side-effect profile.

Research has explored the potential for long-term use, and trial protocols accounted for potential drug-drug interactions.


Safety and Adverse Events

Studies have evaluated whether an effect was detectable in a Phase 2 study of high-dose Vitafluid in a refractory patient population.

The evidence examined adverse event data collected across most populations, including the elderly.

For individuals with liver impairment, the high-dose regimen was not studied, or was observed to present specific safety endpoints.

Initial trials have documented the occurrence of adverse events, which included transient gastrointestinal distress and mild headache, alongside documentation of serious adverse events (SAEs).

Frequently Asked Questions (FAQ)

Common questions about Vitafluid (FAQ)

Q: Does Vitafluid require a prescription, or is it an over-the-counter drug?

A: According to the official product information, Vitafluid is classified as a Prescription Only Medicine (Rx). This means the drug requires a valid prescription from a licensed healthcare provider for it to be legally dispensed.

Q: Is there a generic version of Vitafluid available?

A: Regulatory databases that list approved medications, such as the FDA's Approved Drug Products Database, confirm whether an equivalent generic version of the brand-name drug has been approved for marketing. This information is available by checking regulatory sources that list approved generic substitutes.

Q: Is Vitafluid considered a blood thinner, and how is it different from common anticoagulants?

A: Vitafluid is not categorized as a blood thinner, or anticoagulant. However, the drug label does include specific warnings regarding its use alongside known blood thinners. This potential interaction necessitates a review and potential monitoring by a healthcare provider.

Q: What is the average duration of treatment with Vitafluid?

A: Official dosing guidelines outline a two-phase treatment structure: a short-term, high-dose phase for initial correction, followed by a transition to a long-term, low-dose maintenance regimen. The label defines the maximum duration allowed for the initial high-dose treatment, and the long-term maintenance period is determined by a healthcare provider based on the patient's needs.

Q: Can Vitafluid be taken long-term, or is it typically a short-course treatment?

A: Official instructions confirm that Vitafluid is approved for a long-term, low-dose maintenance regimen following an initial short-term correction phase. Official information outlines the product's intended use in a long-term maintenance phase, which is conducted under a healthcare provider's supervision.

Q: How long does Vitafluid stay in your system after you stop taking it?

A: The time it takes for Vitafluid to leave the body is related to its half-life, which is the time required for half the drug to be cleared. This information, which helps predict the drug’s elimination time, is detailed in the Pharmacokinetics section of the regulatory label.

Q: Are there any dietary restrictions I should be aware of while on Vitafluid?

A: Yes, regulatory administration instructions include a mandatory requirement that Vitafluid be taken with a meal or a lipid/oil source. The active ingredient requires the presence of a lipid source for adequate absorption, which is why this administration condition is mandatory.

Q: Can Vitafluid be crushed or split if a person has trouble swallowing pills?

A: The official label specifies whether the tablet or capsule form is approved for alteration (such as crushing or splitting). Altering dosage forms is only permissible if explicitly stated in the administration instructions, or an alternative form, like the Oral Liquid Preparation, may be used.

Q: Is it important to take Vitafluid at the same time every day?

A: Official dosing instructions specify the required frequency, such as once daily. To ensure consistency, maintaining a consistent dosing time is generally necessary to help achieve and sustain stable drug levels throughout the course of treatment, if required by the label.

Q: Does Vitafluid interact with hormonal birth control or hormone replacement therapy?

A: The regulatory Drug Interactions section specifically lists any known or potential conflicts between Vitafluid and hormonal medications, including contraceptives or hormone replacement therapy. These interactions typically concern effects on drug metabolism and absorption.

Q: Does Vitafluid interact with herbal remedies like St. John's wort or ginseng?

A: While the label warns generally about herbal supplements, the Drug Interactions section may specifically call out high-risk herbal remedies like St. John’s wort or ginseng. These are flagged if they are known to affect the metabolic enzymes that clear the drug from the body.

Q: Are there any special warnings for people who have upcoming surgeries and are taking Vitafluid?

A: Yes, official warnings and precautions often require that Vitafluid be temporarily discontinued before certain surgical procedures. Discontinuation is usually required before surgery, particularly for procedures where the drug's activity might affect blood-related outcomes.

Q: What is the risk of dependence or withdrawal symptoms with Vitafluid?

A: The regulatory label contains a dedicated section on Drug Abuse and Dependence. This section outlines any potential for physical or psychological dependence and documents whether patients experience associated withdrawal symptoms when the medication is stopped.

Q: Can Vitafluid be used by women who are not pregnant or breastfeeding, and what are the general warnings for them?

A: Regulatory documents address the use of Vitafluid in all individuals of reproductive potential. The safety profile outlines specific warnings and required precautions for all individuals of reproductive potential, which often includes requirements for adequate birth control.

Q: Can older adults safely use Vitafluid, and are there special precautions?

A: The regulatory documents provide specific guidelines for use in the geriatric population. This section includes safety, efficacy, and any required dosage adjustments to ensure appropriate use in older adults.

Q: Is Vitafluid considered safe for people with pre-existing kidney or liver conditions?

A: The official label includes specific warnings or contraindications for patients with impaired liver function or kidney disease. These guidelines specify precautions, contraindications, and potential dose adjustments for use in patients with impaired liver function or kidney disease.

Q: How do doctors monitor the effectiveness of Vitafluid in a patient?

A: Effectiveness is monitored by assessing specific clinical or laboratory parameters that were established during the drug's clinical trials. These may include blood tests for active metabolites or other biomarkers relevant to the condition being treated.

Q: Are there any long-term side effects that have been noted with Vitafluid use?

A: The regulatory safety profile documents adverse reactions observed during long-term clinical studies and post-marketing surveillance. These records include information on side effects that may be associated with extended use.

Q: Can Vitafluid affect sleep patterns or cause insomnia?

A: The drug's official safety profile, categorized by system organ class, documents reports of insomnia or other sleep pattern disturbances if they were observed during clinical trials. These are typically listed under Nervous System Disorders.

Q: Can Vitafluid cause changes in mood or energy levels?

A: Changes to mood, such as irritability or depression, or changes to energy levels, such as fatigue, are documented in the Adverse Reactions section if they were reported in clinical studies. They are often categorized under Psychiatric or Nervous System disorders.

Q: Does Vitafluid have any known effects on blood pressure readings?

A: If changes to blood pressure, such as increases or decreases, were observed as an adverse reaction during clinical trials, they would be formally documented in the Adverse Reactions section of the regulatory label under Cardiovascular Disorders.

Q: What should I do if I suspect a severe or unusual side effect from Vitafluid?

A: The patient information provided in the regulatory label instructs individuals on how to recognize and report serious or unusual adverse events. The label provides instruction on the appropriate steps to take, which involves seeking assistance from a healthcare provider or emergency services when a serious reaction is suspected.

How should Vitafluid be stored and disposed of?

Vitafluid must be stored according to the specific requirements listed on its regulatory labeling to maintain its stability and quality. The official instructions define mandatory temperature ranges, which often align with Controlled Room Temperature (20, C to 25, C), and explicitly prohibit conditions like freezing or excessive heat.

Mandatory Storage and Disposal

  • Environmental Protection: The product must be kept in its original packaging to protect it from light and/or moisture.
  • Handling Restriction: The label specifies conditions that must be avoided, such as not storing the product above a certain temperature or, if refrigerated, the prohibition against freezing.
  • Stability Period: If the product is reconstituted or opened, the label states a defined period after which the unused portion must be discarded, regardless of the overall expiration date.
  • Child Safety: All medication must be stored out of the sight and reach of children.
  • Disposal: Unused or expired Vitafluid should be disposed of via a drug take-back program or an authorized collection point. If these are unavailable, follow the official non-flushing guidance: mix the drug with an undesirable substance (like coffee grounds), place it in a sealed container, and discard it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Vitafluid found in:

A-Z Index: